Company Filing History:
1 out of 10 
1 out of 3 Years Active: 2020-2023
Title: Innovations of Kaiyang Tang in Medicinal Applications
Introduction
Kaiyang Tang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly through his innovative work involving IL-22 dimers. With a total of 2 patents, his research focuses on the therapeutic applications of these compounds.
Latest Patents
Kaiyang Tang's latest patents revolve around the use of IL-22 dimers in the manufacture of medicaments for intravenous administration. The applications detail methods for administering an IL-22 dimer to individuals, including humans, by intravenously delivering an effective amount ranging from about 2 µg/kg to about 200 µg/kg. This innovative approach also includes methods for treating diseases through such administration, along with the provision of kits, unit dosages, and articles of manufacture for practical use.
Career Highlights
Throughout his career, Kaiyang Tang has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Generon (Shanghai) Corporation Ltd. and Evive Biotechnology (Shanghai) Ltd. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Kaiyang Tang has collaborated with several professionals in his field, including Xiaoqiang Yan and Cheng Yi Huang. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Kaiyang Tang's work exemplifies the intersection of innovation and medicine, particularly through his patents on IL-22 dimers. His contributions are paving the way for new therapeutic approaches in healthcare.